

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.05368184 |
| 2 | locomotory exploration behavior (GO:0035641) | 4.44908955 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.40004260 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.27781497 |
| 5 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.22038562 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.15392896 |
| 7 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.14825503 |
| 8 | glutamate secretion (GO:0014047) | 4.11193924 |
| 9 | proline transport (GO:0015824) | 4.03896734 |
| 10 | layer formation in cerebral cortex (GO:0021819) | 3.99666358 |
| 11 | activation of protein kinase A activity (GO:0034199) | 3.95437301 |
| 12 | regulation of synapse structural plasticity (GO:0051823) | 3.93268642 |
| 13 | cell communication by electrical coupling (GO:0010644) | 3.92303812 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.84320958 |
| 15 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80273244 |
| 16 | vocalization behavior (GO:0071625) | 3.76955935 |
| 17 | synaptic vesicle exocytosis (GO:0016079) | 3.76008915 |
| 18 | response to peptidoglycan (GO:0032494) | 3.74401200 |
| 19 | sodium ion export (GO:0071436) | 3.71682193 |
| 20 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.66487057 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.51730266 |
| 22 | regulation of ARF protein signal transduction (GO:0032012) | 3.44811736 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.44373916 |
| 24 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.39536087 |
| 25 | exploration behavior (GO:0035640) | 3.38920686 |
| 26 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.36228017 |
| 27 | neutrophil activation involved in immune response (GO:0002283) | 3.34908854 |
| 28 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.34854983 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.33677926 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.31239885 |
| 31 | cell communication involved in cardiac conduction (GO:0086065) | 3.28222020 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.22962085 |
| 33 | regulation of synaptic vesicle transport (GO:1902803) | 3.20731663 |
| 34 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.18850709 |
| 35 | protein localization to synapse (GO:0035418) | 3.17977825 |
| 36 | calcium ion-dependent exocytosis (GO:0017156) | 3.13982849 |
| 37 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.12947112 |
| 38 | membrane depolarization during action potential (GO:0086010) | 3.10868692 |
| 39 | cellular potassium ion homeostasis (GO:0030007) | 3.07836727 |
| 40 | gamma-aminobutyric acid transport (GO:0015812) | 3.07233334 |
| 41 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.06702709 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.03833416 |
| 43 | alanine transport (GO:0032328) | 3.02854791 |
| 44 | response to epinephrine (GO:0071871) | 3.01285646 |
| 45 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.00408013 |
| 46 | macrophage activation involved in immune response (GO:0002281) | 2.99853801 |
| 47 | cellular sodium ion homeostasis (GO:0006883) | 2.98812985 |
| 48 | tricarboxylic acid cycle (GO:0006099) | 2.97309016 |
| 49 | sarcomere organization (GO:0045214) | 2.96443104 |
| 50 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.94654550 |
| 51 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.92664781 |
| 52 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.91159620 |
| 53 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.90296406 |
| 54 | nucleobase catabolic process (GO:0046113) | 2.89511106 |
| 55 | positive regulation of synapse maturation (GO:0090129) | 2.85630748 |
| 56 | cardiac muscle contraction (GO:0060048) | 2.84256599 |
| 57 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.83458283 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 2.82986887 |
| 59 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.81363560 |
| 60 | negative regulation of cell killing (GO:0031342) | 2.79539714 |
| 61 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.79539714 |
| 62 | synaptic transmission, glutamatergic (GO:0035249) | 2.78660115 |
| 63 | germinal center formation (GO:0002467) | 2.75944141 |
| 64 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.74742503 |
| 65 | * carnitine shuttle (GO:0006853) | 2.73869859 |
| 66 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.72765533 |
| 67 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71168630 |
| 68 | sperm motility (GO:0030317) | 2.71042766 |
| 69 | heart contraction (GO:0060047) | 2.70473135 |
| 70 | heart process (GO:0003015) | 2.70473135 |
| 71 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.69573854 |
| 72 | * carnitine transmembrane transport (GO:1902603) | 2.69323972 |
| 73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.69095069 |
| 74 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.68107954 |
| 75 | alpha-linolenic acid metabolic process (GO:0036109) | 2.67513924 |
| 76 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.66904410 |
| 77 | positive regulation of membrane potential (GO:0045838) | 2.66189185 |
| 78 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.64947730 |
| 79 | regulation of relaxation of muscle (GO:1901077) | 2.63988883 |
| 80 | negative regulation of sodium ion transport (GO:0010766) | 2.63844200 |
| 81 | * carnitine transport (GO:0015879) | 2.63153421 |
| 82 | * amino-acid betaine transport (GO:0015838) | 2.63153421 |
| 83 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.62626501 |
| 84 | glycine transport (GO:0015816) | 2.62521531 |
| 85 | modulation by symbiont of host defense response (GO:0052031) | 2.62260132 |
| 86 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.62260132 |
| 87 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.62260132 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.62260132 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 2.62260132 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 2.62260132 |
| 91 | cellular response to epinephrine stimulus (GO:0071872) | 2.61809662 |
| 92 | membrane repolarization (GO:0086009) | 2.61511547 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.60519427 |
| 94 | * fatty acid transmembrane transport (GO:1902001) | 2.60233866 |
| 95 | acrosome reaction (GO:0007340) | 2.58780411 |
| 96 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.58314231 |
| 97 | cellular extravasation (GO:0045123) | 2.57473945 |
| 98 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.57226564 |
| 99 | establishment of nucleus localization (GO:0040023) | 2.57180019 |
| 100 | actin-myosin filament sliding (GO:0033275) | 2.56081963 |
| 101 | muscle filament sliding (GO:0030049) | 2.56081963 |
| 102 | detection of other organism (GO:0098543) | 2.56035846 |
| 103 | myofibril assembly (GO:0030239) | 2.56014083 |
| 104 | macrophage activation (GO:0042116) | 2.55366782 |
| 105 | cardiac myofibril assembly (GO:0055003) | 2.54904566 |
| 106 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.54230176 |
| 107 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.54041219 |
| 108 | long-term memory (GO:0007616) | 2.53958745 |
| 109 | neurotransmitter transport (GO:0006836) | 2.52713466 |
| 110 | lysine catabolic process (GO:0006554) | 2.52482369 |
| 111 | lysine metabolic process (GO:0006553) | 2.52482369 |
| 112 | NADH metabolic process (GO:0006734) | 2.51843986 |
| 113 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51138911 |
| 114 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.50261725 |
| 115 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.50045415 |
| 116 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.50045415 |
| 117 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.49925651 |
| 118 | regulation of synaptic plasticity (GO:0048167) | 2.49691764 |
| 119 | regulation of the force of heart contraction (GO:0002026) | 2.49481287 |
| 120 | cellular ketone body metabolic process (GO:0046950) | 2.49158531 |
| 121 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.48647541 |
| 122 | regulation of ion transmembrane transporter activity (GO:0032412) | 2.48448470 |
| 123 | neuromuscular process controlling balance (GO:0050885) | 2.48273726 |
| 124 | regulation of actin filament-based movement (GO:1903115) | 2.48158218 |
| 125 | detection of calcium ion (GO:0005513) | 2.48053585 |
| 126 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.47872355 |
| 127 | regulation of neurotransmitter levels (GO:0001505) | 2.47058062 |
| 128 | dendrite morphogenesis (GO:0048813) | 2.46779670 |
| 129 | plasma membrane fusion (GO:0045026) | 2.45404436 |
| 130 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.44976989 |
| 131 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.44927033 |
| 132 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.43596145 |
| 133 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.43194378 |
| 134 | glutamate receptor signaling pathway (GO:0007215) | 2.42422009 |
| 135 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.42050802 |
| 136 | succinate metabolic process (GO:0006105) | 2.41474047 |
| 137 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.41463904 |
| 138 | regulation of transmembrane transporter activity (GO:0022898) | 2.39956723 |
| 139 | neutral lipid catabolic process (GO:0046461) | 2.38910021 |
| 140 | acylglycerol catabolic process (GO:0046464) | 2.38910021 |
| 141 | regulation of T cell tolerance induction (GO:0002664) | 2.38324038 |
| 142 | potassium ion import (GO:0010107) | 2.37916916 |
| 143 | vesicle transport along microtubule (GO:0047496) | 2.37579832 |
| 144 | cardiac muscle hypertrophy (GO:0003300) | 2.36470750 |
| 145 | detection of molecule of bacterial origin (GO:0032490) | 2.35482290 |
| 146 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.34988936 |
| 147 | granulocyte activation (GO:0036230) | 2.33719395 |
| 148 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.31134358 |
| 149 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.30001172 |
| 150 | detection of bacterium (GO:0016045) | 2.29832766 |
| 151 | response to thyroid hormone (GO:0097066) | 2.29495806 |
| 152 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.29101371 |
| 153 | Rap protein signal transduction (GO:0032486) | 2.28272654 |
| 154 | striated muscle atrophy (GO:0014891) | 2.28198577 |
| 155 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.27532020 |
| 156 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.25962148 |
| 157 | regulation of gamma-delta T cell activation (GO:0046643) | 2.25492846 |
| 158 | type I interferon signaling pathway (GO:0060337) | 2.24146214 |
| 159 | cellular response to type I interferon (GO:0071357) | 2.24146214 |
| 160 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.24019292 |
| 161 | neutrophil activation (GO:0042119) | 2.23394326 |
| 162 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.23161019 |
| 163 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.22999719 |
| 164 | relaxation of cardiac muscle (GO:0055119) | 2.22378362 |
| 165 | positive regulation of type 2 immune response (GO:0002830) | 2.22316715 |
| 166 | regulation of tolerance induction (GO:0002643) | 2.21928642 |
| 167 | macroautophagy (GO:0016236) | 2.21292191 |
| 168 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.21271655 |
| 169 | membrane raft organization (GO:0031579) | 2.21225777 |
| 170 | positive regulation of antigen processing and presentation (GO:0002579) | 2.21203147 |
| 171 | regulation of striated muscle contraction (GO:0006942) | 2.21172820 |
| 172 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.20900316 |
| 173 | response to type I interferon (GO:0034340) | 2.20540191 |
| 174 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.20407163 |
| 175 | response to muramyl dipeptide (GO:0032495) | 2.20015000 |
| 176 | striated muscle hypertrophy (GO:0014897) | 2.18732085 |
| 177 | defense response to protozoan (GO:0042832) | 2.16822418 |
| 178 | actin-mediated cell contraction (GO:0070252) | 2.15803961 |
| 179 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.15566863 |
| 180 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.15553230 |
| 181 | detection of external biotic stimulus (GO:0098581) | 2.15492208 |
| 182 | regulation of chemokine biosynthetic process (GO:0045073) | 2.15179961 |
| 183 | regulation of cardiac muscle contraction (GO:0055117) | 2.14710510 |
| 184 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.13545506 |
| 185 | positive regulation of tolerance induction (GO:0002645) | 2.13010854 |
| 186 | negative regulation of interleukin-17 production (GO:0032700) | 2.11786050 |
| 187 | regulation of antigen processing and presentation (GO:0002577) | 2.11761082 |
| 188 | response to protozoan (GO:0001562) | 2.11703907 |
| 189 | T-helper 1 type immune response (GO:0042088) | 2.11575320 |
| 190 | establishment of endothelial barrier (GO:0061028) | 2.10872595 |
| 191 | regulation of mast cell degranulation (GO:0043304) | 2.10510548 |
| 192 | muscle hypertrophy (GO:0014896) | 2.10278788 |
| 193 | immunoglobulin mediated immune response (GO:0016064) | 2.09991279 |
| 194 | regulation of necroptotic process (GO:0060544) | 2.08735767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.11412175 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.16030838 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.36035176 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.09900291 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.09089908 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60609415 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48122281 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.45452669 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.42758167 |
| 10 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.42554787 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.39892895 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.38902851 |
| 13 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.38753223 |
| 14 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37548188 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37458746 |
| 16 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.34681338 |
| 17 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.30769484 |
| 18 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.21746349 |
| 19 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.20247376 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15527397 |
| 21 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12138906 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.11646487 |
| 23 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.06777505 |
| 24 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.02838195 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.96642032 |
| 26 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.96089851 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.95822265 |
| 28 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94395336 |
| 29 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88148675 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87328257 |
| 31 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.86176205 |
| 32 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.85705483 |
| 33 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.85666460 |
| 34 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82642887 |
| 35 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.74845730 |
| 36 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.74570256 |
| 37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74280890 |
| 38 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.71843962 |
| 39 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71701260 |
| 40 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71701260 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.70615350 |
| 42 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64791520 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.64649395 |
| 44 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.62949128 |
| 45 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.62296387 |
| 46 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60309855 |
| 47 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.59414935 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.57150997 |
| 49 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56705024 |
| 50 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.55388533 |
| 51 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50564236 |
| 52 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.48574289 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48259701 |
| 54 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.48249469 |
| 55 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46948190 |
| 56 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45470309 |
| 57 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.44768577 |
| 58 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.42243553 |
| 59 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41432454 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.37464174 |
| 61 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36106700 |
| 62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35523475 |
| 63 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.35504537 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33823633 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33819915 |
| 66 | CJUN_26792858_Chip-Seq_BT549_Human | 1.32400431 |
| 67 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.31822310 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30028243 |
| 69 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29076994 |
| 70 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29076994 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26700083 |
| 72 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26492927 |
| 73 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.26256578 |
| 74 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25617534 |
| 75 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.25560059 |
| 76 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.23976072 |
| 77 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.23496427 |
| 78 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22270343 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.22250533 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.22250533 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20058748 |
| 82 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18358808 |
| 83 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18070549 |
| 84 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17579431 |
| 85 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.16303259 |
| 86 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.16303259 |
| 87 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.16157927 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15570541 |
| 89 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.15548341 |
| 90 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.15225829 |
| 91 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13908992 |
| 92 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.13775533 |
| 93 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.13657986 |
| 94 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.12281395 |
| 95 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11982686 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.10918430 |
| 97 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10846355 |
| 98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10384783 |
| 99 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09880134 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.08818006 |
| 101 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07711127 |
| 102 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07108621 |
| 103 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.06332763 |
| 104 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06301742 |
| 105 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.05819802 |
| 106 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.05233244 |
| 107 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.04152381 |
| 108 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.03986543 |
| 109 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.03862306 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.02719965 |
| 111 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00680881 |
| 112 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00337505 |
| 113 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00300408 |
| 114 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.99828860 |
| 115 | * AR_19668381_ChIP-Seq_PC3_Human | 0.98421889 |
| 116 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98284846 |
| 117 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98128656 |
| 118 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97578228 |
| 119 | AR_25329375_ChIP-Seq_VCAP_Human | 0.97546806 |
| 120 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.96130251 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95675618 |
| 122 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95584466 |
| 123 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.95433387 |
| 124 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.95359779 |
| 125 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95345560 |
| 126 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95301934 |
| 127 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.95254314 |
| 128 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94745579 |
| 129 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94568758 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94037838 |
| 131 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.93114295 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92310802 |
| 133 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92179620 |
| 134 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.91999549 |
| 135 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91831636 |
| 136 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90803362 |
| 137 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.90544949 |
| 138 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90091068 |
| 139 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.89788763 |
| 140 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.89434405 |
| 141 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89277439 |
| 142 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.88977272 |
| 143 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88670674 |
| 144 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88206979 |
| 145 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.87742519 |
| 146 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.87585068 |
| 147 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87292060 |
| 148 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87286379 |
| 149 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86851115 |
| 150 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86826768 |
| 151 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.86731065 |
| 152 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85539596 |
| 153 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85493702 |
| 154 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.85400263 |
| 155 | MYB_26560356_Chip-Seq_TH2_Human | 0.85314095 |
| 156 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84458202 |
| 157 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84365652 |
| 158 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83263764 |
| 159 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.83202850 |
| 160 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83178349 |
| 161 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.82884119 |
| 162 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.82529741 |
| 163 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82509893 |
| 164 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.82198029 |
| 165 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.82198029 |
| 166 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.82189394 |
| 167 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81174371 |
| 168 | GATA2_19941826_ChIP-Seq_K562_Human | 0.80857544 |
| 169 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80790180 |
| 170 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79954958 |
| 171 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79517638 |
| 172 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.79515014 |
| 173 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.77785036 |
| 174 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.77171885 |
| 175 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.77096267 |
| 176 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76347858 |
| 177 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.76081616 |
| 178 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.75972984 |
| 179 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.75382025 |
| 180 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.75082428 |
| 181 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.74887130 |
| 182 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74615641 |
| 183 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.74378041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.99673083 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.30186510 |
| 3 | MP0003303_peritoneal_inflammation | 3.24825890 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.23315818 |
| 5 | MP0004270_analgesia | 2.96959553 |
| 6 | MP0003724_increased_susceptibility_to | 2.95274656 |
| 7 | MP0002822_catalepsy | 2.59981869 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.57711381 |
| 9 | MP0005410_abnormal_fertilization | 2.56871050 |
| 10 | MP0003880_abnormal_central_pattern | 2.56783144 |
| 11 | MP0001968_abnormal_touch/_nociception | 2.55218168 |
| 12 | MP0009745_abnormal_behavioral_response | 2.48324781 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.43071385 |
| 14 | MP0002909_abnormal_adrenal_gland | 2.38237801 |
| 15 | MP0003828_pulmonary_edema | 2.34037621 |
| 16 | MP0004130_abnormal_muscle_cell | 2.32236032 |
| 17 | MP0005360_urolithiasis | 2.27635452 |
| 18 | MP0006082_CNS_inflammation | 2.21783231 |
| 19 | MP0005365_abnormal_bile_salt | 2.20193887 |
| 20 | MP0009780_abnormal_chondrocyte_physiolo | 2.18606704 |
| 21 | MP0003436_decreased_susceptibility_to | 2.18415266 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.13571959 |
| 23 | MP0009840_abnormal_foam_cell | 2.12573625 |
| 24 | MP0009785_altered_susceptibility_to | 2.04672170 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 2.03963100 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.03245203 |
| 27 | MP0002064_seizures | 1.99466115 |
| 28 | MP0002736_abnormal_nociception_after | 1.99052503 |
| 29 | MP0002332_abnormal_exercise_endurance | 1.95499895 |
| 30 | MP0002234_abnormal_pharynx_morphology | 1.90989609 |
| 31 | MP0003300_gastrointestinal_ulcer | 1.88742099 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.88276214 |
| 33 | MP0003172_abnormal_lysosome_physiology | 1.86024500 |
| 34 | MP0003950_abnormal_plasma_membrane | 1.83646813 |
| 35 | MP0002419_abnormal_innate_immunity | 1.83126820 |
| 36 | MP0010329_abnormal_lipoprotein_level | 1.82889695 |
| 37 | MP0001835_abnormal_antigen_presentation | 1.81656487 |
| 38 | MP0002734_abnormal_mechanical_nocicepti | 1.81184957 |
| 39 | MP0003329_amyloid_beta_deposits | 1.78732813 |
| 40 | MP0008875_abnormal_xenobiotic_pharmacok | 1.78084490 |
| 41 | MP0009046_muscle_twitch | 1.72788767 |
| 42 | MP0000343_altered_response_to | 1.71169045 |
| 43 | MP0005423_abnormal_somatic_nervous | 1.70088523 |
| 44 | MP0005000_abnormal_immune_tolerance | 1.69742558 |
| 45 | MP0005058_abnormal_lysosome_morphology | 1.69382956 |
| 46 | MP0005165_increased_susceptibility_to | 1.67517770 |
| 47 | MP0008961_abnormal_basal_metabolism | 1.67019952 |
| 48 | MP0004811_abnormal_neuron_physiology | 1.63660546 |
| 49 | MP0008569_lethality_at_weaning | 1.62749515 |
| 50 | MP0005670_abnormal_white_adipose | 1.61308808 |
| 51 | MP0002733_abnormal_thermal_nociception | 1.61243224 |
| 52 | MP0005451_abnormal_body_composition | 1.60945191 |
| 53 | MP0002272_abnormal_nervous_system | 1.59979724 |
| 54 | MP0001790_abnormal_immune_system | 1.59657441 |
| 55 | MP0005387_immune_system_phenotype | 1.59657441 |
| 56 | MP0004858_abnormal_nervous_system | 1.58258007 |
| 57 | MP0003868_abnormal_feces_composition | 1.56692663 |
| 58 | MP0000749_muscle_degeneration | 1.54069469 |
| 59 | MP0000569_abnormal_digit_pigmentation | 1.51041802 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 1.50804474 |
| 61 | MP0005535_abnormal_body_temperature | 1.50139864 |
| 62 | MP0003252_abnormal_bile_duct | 1.50117232 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.48787064 |
| 64 | MP0003879_abnormal_hair_cell | 1.47043005 |
| 65 | MP0005025_abnormal_response_to | 1.45630877 |
| 66 | MP0005166_decreased_susceptibility_to | 1.43506768 |
| 67 | MP0008004_abnormal_stomach_pH | 1.41864257 |
| 68 | MP0003787_abnormal_imprinting | 1.39770820 |
| 69 | MP0009764_decreased_sensitivity_to | 1.38512129 |
| 70 | MP0001486_abnormal_startle_reflex | 1.37684902 |
| 71 | MP0000751_myopathy | 1.36958698 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.36364518 |
| 73 | MP0001501_abnormal_sleep_pattern | 1.34226518 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.33620271 |
| 75 | MP0003633_abnormal_nervous_system | 1.33216132 |
| 76 | MP0002723_abnormal_immune_serum | 1.32700005 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.31411746 |
| 78 | MP0004924_abnormal_behavior | 1.31411746 |
| 79 | MP0004215_abnormal_myocardial_fiber | 1.29757735 |
| 80 | MP0001970_abnormal_pain_threshold | 1.28582837 |
| 81 | MP0002067_abnormal_sensory_capabilities | 1.25777797 |
| 82 | MP0001800_abnormal_humoral_immune | 1.24520245 |
| 83 | MP0005164_abnormal_response_to | 1.24168292 |
| 84 | MP0002998_abnormal_bone_remodeling | 1.22318321 |
| 85 | MP0003183_abnormal_peptide_metabolism | 1.22282510 |
| 86 | MP0001845_abnormal_inflammatory_respons | 1.22237018 |
| 87 | MP0003690_abnormal_glial_cell | 1.21414893 |
| 88 | MP0002118_abnormal_lipid_homeostasis | 1.21378815 |
| 89 | MP0005671_abnormal_response_to | 1.20680085 |
| 90 | MP0004087_abnormal_muscle_fiber | 1.20449230 |
| 91 | MP0001440_abnormal_grooming_behavior | 1.20194883 |
| 92 | MP0005464_abnormal_platelet_physiology | 1.18795251 |
| 93 | MP0004084_abnormal_cardiac_muscle | 1.18475568 |
| 94 | MP0006276_abnormal_autonomic_nervous | 1.17059596 |
| 95 | MP0003091_abnormal_cell_migration | 1.17025114 |
| 96 | MP0004510_myositis | 1.16438011 |
| 97 | MP0004085_abnormal_heartbeat | 1.15614484 |
| 98 | MP0000955_abnormal_spinal_cord | 1.14688100 |
| 99 | MP0005385_cardiovascular_system_phenoty | 1.14055799 |
| 100 | MP0001544_abnormal_cardiovascular_syste | 1.14055799 |
| 101 | MP0003195_calcinosis | 1.13860174 |
| 102 | MP0004947_skin_inflammation | 1.11348657 |
| 103 | MP0003656_abnormal_erythrocyte_physiolo | 1.11257343 |
| 104 | MP0002557_abnormal_social/conspecific_i | 1.11083172 |
| 105 | MP0004036_abnormal_muscle_relaxation | 1.10870953 |
| 106 | MP0002420_abnormal_adaptive_immunity | 1.10589537 |
| 107 | MP0003279_aneurysm | 1.10482487 |
| 108 | MP0010155_abnormal_intestine_physiology | 1.10097237 |
| 109 | MP0001819_abnormal_immune_cell | 1.10054599 |
| 110 | MP0000685_abnormal_immune_system | 1.10028702 |
| 111 | MP0008469_abnormal_protein_level | 1.08812574 |
| 112 | MP0002138_abnormal_hepatobiliary_system | 1.08729651 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08712630 |
| 114 | MP0001851_eye_inflammation | 1.08471125 |
| 115 | MP0008872_abnormal_physiological_respon | 1.07958561 |
| 116 | MP0006138_congestive_heart_failure | 1.06063404 |
| 117 | MP0006054_spinal_hemorrhage | 1.05537724 |
| 118 | MP0002078_abnormal_glucose_homeostasis | 1.04025246 |
| 119 | MP0005397_hematopoietic_system_phenotyp | 1.03241250 |
| 120 | MP0001545_abnormal_hematopoietic_system | 1.03241250 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 1.02515654 |
| 122 | MP0004883_abnormal_blood_vessel | 1.01087383 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.99932579 |
| 124 | MP0000604_amyloidosis | 0.99835042 |
| 125 | MP0001853_heart_inflammation | 0.99592243 |
| 126 | MP0003698_abnormal_male_reproductive | 0.99189888 |
| 127 | MP0003646_muscle_fatigue | 0.99025774 |
| 128 | MP0001765_abnormal_ion_homeostasis | 0.98907209 |
| 129 | MP0008874_decreased_physiological_sensi | 0.98036691 |
| 130 | MP0004043_abnormal_pH_regulation | 0.97547617 |
| 131 | MP0004233_abnormal_muscle_weight | 0.96799985 |
| 132 | MP0002405_respiratory_system_inflammati | 0.95735828 |
| 133 | MP0000465_gastrointestinal_hemorrhage | 0.94249796 |
| 134 | MP0005448_abnormal_energy_balance | 0.93894812 |
| 135 | MP0003566_abnormal_cell_adhesion | 0.93640030 |
| 136 | MP0003075_altered_response_to | 0.93254838 |
| 137 | MP0001666_abnormal_nutrient_absorption | 0.92566331 |
| 138 | MP0010630_abnormal_cardiac_muscle | 0.91170875 |
| 139 | MP0002184_abnormal_innervation | 0.90706242 |
| 140 | MP0005332_abnormal_amino_acid | 0.90542696 |
| 141 | MP0002066_abnormal_motor_capabilities/c | 0.90348716 |
| 142 | MP0002269_muscular_atrophy | 0.89494507 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.88282675 |
| 144 | MP0000013_abnormal_adipose_tissue | 0.87166035 |
| 145 | MP0005666_abnormal_adipose_tissue | 0.87130118 |
| 146 | MP0003631_nervous_system_phenotype | 0.86704086 |
| 147 | MP0002069_abnormal_eating/drinking_beha | 0.86604383 |
| 148 | MP0005330_cardiomyopathy | 0.85882016 |
| 149 | MP0001727_abnormal_embryo_implantation | 0.85828427 |
| 150 | MP0006036_abnormal_mitochondrial_physio | 0.85300382 |
| 151 | MP0008260_abnormal_autophagy | 0.85210943 |
| 152 | MP0004484_altered_response_of | 0.84726117 |
| 153 | MP0003448_altered_tumor_morphology | 0.84011778 |
| 154 | MP0000249_abnormal_blood_vessel | 0.83630494 |
| 155 | MP0001502_abnormal_circadian_rhythm | 0.83380206 |
| 156 | MP0002971_abnormal_brown_adipose | 0.83299011 |
| 157 | MP0005595_abnormal_vascular_smooth | 0.82886729 |
| 158 | MP0005620_abnormal_muscle_contractility | 0.82769378 |
| 159 | MP0003191_abnormal_cellular_cholesterol | 0.82408091 |
| 160 | MP0009763_increased_sensitivity_to | 0.79717469 |
| 161 | MP0003953_abnormal_hormone_level | 0.79659643 |
| 162 | MP0003283_abnormal_digestive_organ | 0.79289540 |
| 163 | MP0002972_abnormal_cardiac_muscle | 0.78840039 |
| 164 | MP0009278_abnormal_bone_marrow | 0.78386440 |
| 165 | MP0003221_abnormal_cardiomyocyte_apopto | 0.78085634 |
| 166 | MP0000747_muscle_weakness | 0.78007603 |
| 167 | MP0002127_abnormal_cardiovascular_syste | 0.77489503 |
| 168 | MP0005319_abnormal_enzyme/_coenzyme | 0.75898126 |
| 169 | MP0003045_fibrosis | 0.75218907 |
| 170 | MP0000230_abnormal_systemic_arterial | 0.75155596 |
| 171 | MP0004885_abnormal_endolymph | 0.74949365 |
| 172 | MP0008775_abnormal_heart_ventricle | 0.72963792 |
| 173 | MP0001984_abnormal_olfaction | 0.72261659 |
| 174 | MP0001348_abnormal_lacrimal_gland | 0.72153508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.82287904 |
| 2 | Focal motor seizures (HP:0011153) | 4.35079657 |
| 3 | Papilledema (HP:0001085) | 4.29762049 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.19395616 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.19395616 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.19395616 |
| 7 | Visual hallucinations (HP:0002367) | 4.17830920 |
| 8 | Abnormality of the lower motor neuron (HP:0002366) | 3.88748321 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 3.56171042 |
| 10 | Focal seizures (HP:0007359) | 3.48597110 |
| 11 | Stomatitis (HP:0010280) | 3.46291639 |
| 12 | * Asymmetric septal hypertrophy (HP:0001670) | 3.43999153 |
| 13 | Ventricular tachycardia (HP:0004756) | 3.36121498 |
| 14 | Muscle fiber splitting (HP:0003555) | 3.35685662 |
| 15 | * Atrial fibrillation (HP:0005110) | 3.33332983 |
| 16 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.13469259 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.13469259 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.10317107 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.08981899 |
| 20 | Exercise-induced myalgia (HP:0003738) | 3.06998677 |
| 21 | Action tremor (HP:0002345) | 3.04085327 |
| 22 | Orchitis (HP:0100796) | 3.01829773 |
| 23 | * Primary atrial arrhythmia (HP:0001692) | 3.01503277 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.00226282 |
| 25 | Myositis (HP:0100614) | 2.96906187 |
| 26 | Progressive cerebellar ataxia (HP:0002073) | 2.95908497 |
| 27 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92651162 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92651162 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92651162 |
| 30 | Right ventricular cardiomyopathy (HP:0011663) | 2.88155513 |
| 31 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.85552105 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.85552105 |
| 33 | Lipoatrophy (HP:0100578) | 2.85303697 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.83460321 |
| 35 | Optic neuritis (HP:0100653) | 2.83460321 |
| 36 | * Supraventricular tachycardia (HP:0004755) | 2.83239580 |
| 37 | Poor eye contact (HP:0000817) | 2.82791196 |
| 38 | Ventricular fibrillation (HP:0001663) | 2.82464976 |
| 39 | Eczematoid dermatitis (HP:0000976) | 2.80429150 |
| 40 | Abnormal social behavior (HP:0012433) | 2.79499203 |
| 41 | Impaired social interactions (HP:0000735) | 2.79499203 |
| 42 | * Supraventricular arrhythmia (HP:0005115) | 2.77075528 |
| 43 | * Ventricular arrhythmia (HP:0004308) | 2.76788864 |
| 44 | Myoglobinuria (HP:0002913) | 2.75335504 |
| 45 | Ketoacidosis (HP:0001993) | 2.74181903 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.74067040 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.72507308 |
| 48 | Postural instability (HP:0002172) | 2.71243302 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.71110858 |
| 50 | Cholecystitis (HP:0001082) | 2.71110858 |
| 51 | Ketosis (HP:0001946) | 2.69310509 |
| 52 | Sudden death (HP:0001699) | 2.65926251 |
| 53 | Epileptic encephalopathy (HP:0200134) | 2.64981426 |
| 54 | Depression (HP:0000716) | 2.59086726 |
| 55 | Dysmetric saccades (HP:0000641) | 2.58768330 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.58445791 |
| 57 | Loss of speech (HP:0002371) | 2.58180516 |
| 58 | Recurrent abscess formation (HP:0002722) | 2.55957236 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53738540 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.51622584 |
| 61 | Vacuolated lymphocytes (HP:0001922) | 2.50797182 |
| 62 | Amyloidosis (HP:0011034) | 2.49465758 |
| 63 | Progressive inability to walk (HP:0002505) | 2.46613797 |
| 64 | Febrile seizures (HP:0002373) | 2.44967666 |
| 65 | Spondylolisthesis (HP:0003302) | 2.44318282 |
| 66 | EMG: myopathic abnormalities (HP:0003458) | 2.43616330 |
| 67 | Supranuclear gaze palsy (HP:0000605) | 2.42148643 |
| 68 | Ankle clonus (HP:0011448) | 2.40172088 |
| 69 | Abnormal eating behavior (HP:0100738) | 2.37783523 |
| 70 | Hypoglycemic coma (HP:0001325) | 2.37691382 |
| 71 | Gaze-evoked nystagmus (HP:0000640) | 2.33376734 |
| 72 | Torticollis (HP:0000473) | 2.32478130 |
| 73 | Dilated cardiomyopathy (HP:0001644) | 2.31548487 |
| 74 | Focal dystonia (HP:0004373) | 2.31375388 |
| 75 | * Heart block (HP:0012722) | 2.28290931 |
| 76 | Deep venous thrombosis (HP:0002625) | 2.26832441 |
| 77 | Impaired vibratory sensation (HP:0002495) | 2.25085890 |
| 78 | * Abnormal atrioventricular conduction (HP:0005150) | 2.23787816 |
| 79 | Scanning speech (HP:0002168) | 2.23518399 |
| 80 | Hyperacusis (HP:0010780) | 2.23248241 |
| 81 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.23127426 |
| 82 | Abnormality of the calf musculature (HP:0001430) | 2.21378809 |
| 83 | Anxiety (HP:0000739) | 2.21335858 |
| 84 | Syncope (HP:0001279) | 2.20691340 |
| 85 | Urinary urgency (HP:0000012) | 2.20286371 |
| 86 | Generalized tonic-clonic seizures (HP:0002069) | 2.19734881 |
| 87 | Hyperventilation (HP:0002883) | 2.19570469 |
| 88 | Pheochromocytoma (HP:0002666) | 2.19403441 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19380632 |
| 90 | Hyperammonemia (HP:0001987) | 2.19020683 |
| 91 | Mutism (HP:0002300) | 2.18784328 |
| 92 | Neurofibrillary tangles (HP:0002185) | 2.18694167 |
| 93 | Ragged-red muscle fibers (HP:0003200) | 2.18200582 |
| 94 | * Palpitations (HP:0001962) | 2.17520411 |
| 95 | Amyotrophic lateral sclerosis (HP:0007354) | 2.16737726 |
| 96 | Genetic anticipation (HP:0003743) | 2.16413715 |
| 97 | Systemic lupus erythematosus (HP:0002725) | 2.15504742 |
| 98 | Craniofacial dystonia (HP:0012179) | 2.15332044 |
| 99 | Disinhibition (HP:0000734) | 2.15034912 |
| 100 | Hypercortisolism (HP:0001578) | 2.13406728 |
| 101 | Truncal ataxia (HP:0002078) | 2.12550219 |
| 102 | Subaortic stenosis (HP:0001682) | 2.12324241 |
| 103 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.12324241 |
| 104 | Agitation (HP:0000713) | 2.10447147 |
| 105 | Bradykinesia (HP:0002067) | 2.08383664 |
| 106 | Status epilepticus (HP:0002133) | 2.07572013 |
| 107 | * Abnormal EKG (HP:0003115) | 2.06114926 |
| 108 | Infertility (HP:0000789) | 2.04619238 |
| 109 | Elfin facies (HP:0004428) | 2.04273931 |
| 110 | Increased CSF protein (HP:0002922) | 2.04164557 |
| 111 | Pulmonary infiltrates (HP:0002113) | 2.02745622 |
| 112 | Nuclear cataract (HP:0100018) | 2.01995781 |
| 113 | * Atrioventricular block (HP:0001678) | 2.01636876 |
| 114 | Spinal canal stenosis (HP:0003416) | 2.01438448 |
| 115 | Amblyopia (HP:0000646) | 2.00515020 |
| 116 | Impaired smooth pursuit (HP:0007772) | 2.00313736 |
| 117 | Dysdiadochokinesis (HP:0002075) | 2.00004804 |
| 118 | Prolonged QT interval (HP:0001657) | 1.99793810 |
| 119 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99686774 |
| 120 | Insomnia (HP:0100785) | 1.99480019 |
| 121 | Neonatal onset (HP:0003623) | 1.99127627 |
| 122 | Absence seizures (HP:0002121) | 1.98586328 |
| 123 | Annular pancreas (HP:0001734) | 1.96774297 |
| 124 | Sensorimotor neuropathy (HP:0007141) | 1.95022247 |
| 125 | Hemoptysis (HP:0002105) | 1.92377827 |
| 126 | Hemiplegia (HP:0002301) | 1.92059126 |
| 127 | Spontaneous abortion (HP:0005268) | 1.90623556 |
| 128 | Hematochezia (HP:0002573) | 1.90394810 |
| 129 | Pointed chin (HP:0000307) | 1.89386894 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.86765116 |
| 131 | Keratoconjunctivitis sicca (HP:0001097) | 1.86617953 |
| 132 | Intention tremor (HP:0002080) | 1.85878406 |
| 133 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.85559839 |
| 134 | Axonal loss (HP:0003447) | 1.85397965 |
| 135 | Vertigo (HP:0002321) | 1.85340118 |
| 136 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.85127983 |
| 137 | Frequent falls (HP:0002359) | 1.84628435 |
| 138 | Atonic seizures (HP:0010819) | 1.83100650 |
| 139 | Abnormality of the endocardium (HP:0004306) | 1.82899001 |
| 140 | Malnutrition (HP:0004395) | 1.82855879 |
| 141 | Inability to walk (HP:0002540) | 1.82628895 |
| 142 | Arterial thrombosis (HP:0004420) | 1.82460314 |
| 143 | Episodic fever (HP:0001954) | 1.81793571 |
| 144 | Mediastinal lymphadenopathy (HP:0100721) | 1.81788701 |
| 145 | Myocardial infarction (HP:0001658) | 1.80686961 |
| 146 | Renovascular hypertension (HP:0100817) | 1.79660466 |
| 147 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.79338261 |
| 148 | Dialeptic seizures (HP:0011146) | 1.79270184 |
| 149 | Metaphyseal dysplasia (HP:0100255) | 1.79257437 |
| 150 | Termporal pattern (HP:0011008) | 1.78908906 |
| 151 | Insidious onset (HP:0003587) | 1.78908906 |
| 152 | Drooling (HP:0002307) | 1.78292176 |
| 153 | Excessive salivation (HP:0003781) | 1.78292176 |
| 154 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77934636 |
| 155 | * Bundle branch block (HP:0011710) | 1.77303007 |
| 156 | Distal lower limb amyotrophy (HP:0008944) | 1.77235200 |
| 157 | Lower limb muscle weakness (HP:0007340) | 1.77158004 |
| 158 | Oligomenorrhea (HP:0000876) | 1.77065731 |
| 159 | Dysmetria (HP:0001310) | 1.76942537 |
| 160 | Neuroendocrine neoplasm (HP:0100634) | 1.76396691 |
| 161 | Neck muscle weakness (HP:0000467) | 1.75877356 |
| 162 | Intrahepatic cholestasis (HP:0001406) | 1.75694467 |
| 163 | Progressive neurologic deterioration (HP:0002344) | 1.73819280 |
| 164 | Long toe (HP:0010511) | 1.72993202 |
| 165 | * Sudden cardiac death (HP:0001645) | 1.72900427 |
| 166 | Complement deficiency (HP:0004431) | 1.72737954 |
| 167 | Clonus (HP:0002169) | 1.72076187 |
| 168 | Growth hormone excess (HP:0000845) | 1.71812683 |
| 169 | Cerebral inclusion bodies (HP:0100314) | 1.71655976 |
| 170 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.71438761 |
| 171 | Impaired pain sensation (HP:0007328) | 1.71396848 |
| 172 | Abnormality of pain sensation (HP:0010832) | 1.71396848 |
| 173 | Lymphangioma (HP:0100764) | 1.71282225 |
| 174 | Keratoconjunctivitis (HP:0001096) | 1.71027887 |
| 175 | Slow saccadic eye movements (HP:0000514) | 1.70940201 |
| 176 | Recurrent skin infections (HP:0001581) | 1.70684614 |
| 177 | Abnormality of saccadic eye movements (HP:0000570) | 1.70558097 |
| 178 | Vasculitis (HP:0002633) | 1.70126988 |
| 179 | Recurrent fungal infections (HP:0002841) | 1.67847266 |
| 180 | Pulmonary embolism (HP:0002204) | 1.67335208 |
| 181 | Interstitial pulmonary disease (HP:0006530) | 1.65656058 |
| 182 | Osteolytic defects of the hand bones (HP:0009699) | 1.65187969 |
| 183 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.65187969 |
| 184 | Calf muscle hypertrophy (HP:0008981) | 1.63407832 |
| 185 | Polyneuropathy (HP:0001271) | 1.61088267 |
| 186 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.59620557 |
| 187 | Abnormality of proline metabolism (HP:0010907) | 1.59206716 |
| 188 | Hydroxyprolinuria (HP:0003080) | 1.59206716 |
| 189 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.58216131 |
| 190 | Muscle fibrillation (HP:0010546) | 1.57788937 |
| 191 | Glomerulonephritis (HP:0000099) | 1.56928002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.09056474 |
| 2 | IRAK3 | 3.12363687 |
| 3 | MAP3K9 | 3.08128295 |
| 4 | PDK3 | 3.01030062 |
| 5 | PDK4 | 3.01030062 |
| 6 | DAPK2 | 2.82963277 |
| 7 | MARK1 | 2.75844773 |
| 8 | PRKD3 | 2.70755643 |
| 9 | EPHA4 | 2.58800596 |
| 10 | MINK1 | 2.48680434 |
| 11 | TRPM7 | 2.29669623 |
| 12 | MAP3K3 | 2.28707203 |
| 13 | MAP3K4 | 2.22658709 |
| 14 | CAMKK1 | 2.21986545 |
| 15 | LMTK2 | 2.17909828 |
| 16 | TGFBR2 | 2.11885742 |
| 17 | MAP2K3 | 2.11640135 |
| 18 | PKN2 | 2.09537380 |
| 19 | GRK7 | 2.04892506 |
| 20 | TRIB3 | 1.94145533 |
| 21 | KSR2 | 1.89377023 |
| 22 | MAP2K7 | 1.85711673 |
| 23 | MAP2K4 | 1.83684951 |
| 24 | MAP3K14 | 1.83656056 |
| 25 | TTN | 1.81252699 |
| 26 | TYK2 | 1.78713702 |
| 27 | TBK1 | 1.77894714 |
| 28 | DAPK1 | 1.70199132 |
| 29 | BLK | 1.67769859 |
| 30 | ZAP70 | 1.65747916 |
| 31 | STK38 | 1.57878741 |
| 32 | RIPK1 | 1.57699735 |
| 33 | MAP3K12 | 1.56950930 |
| 34 | MOS | 1.55022851 |
| 35 | PAK6 | 1.50616090 |
| 36 | CSK | 1.49482736 |
| 37 | EPHB1 | 1.49328247 |
| 38 | FRK | 1.47358325 |
| 39 | DMPK | 1.43742408 |
| 40 | TXK | 1.43461019 |
| 41 | BMPR2 | 1.38359282 |
| 42 | CAMKK2 | 1.36037494 |
| 43 | JAK1 | 1.33572013 |
| 44 | RET | 1.33339437 |
| 45 | OBSCN | 1.32665697 |
| 46 | PDK2 | 1.30036310 |
| 47 | PTK2B | 1.29741920 |
| 48 | PHKG1 | 1.28886188 |
| 49 | PHKG2 | 1.28886188 |
| 50 | MAP3K5 | 1.27887569 |
| 51 | KSR1 | 1.25955023 |
| 52 | ACVR1B | 1.25909310 |
| 53 | TAOK1 | 1.25297560 |
| 54 | IRAK4 | 1.24639021 |
| 55 | ARAF | 1.24602590 |
| 56 | PDK1 | 1.22959771 |
| 57 | MAP3K2 | 1.22805170 |
| 58 | NEK1 | 1.21371364 |
| 59 | BCKDK | 1.19819276 |
| 60 | JAK3 | 1.17083878 |
| 61 | TESK1 | 1.17002476 |
| 62 | MAPK13 | 1.16406318 |
| 63 | IKBKE | 1.16342914 |
| 64 | NTRK2 | 1.14733588 |
| 65 | CDK5 | 1.14619530 |
| 66 | PINK1 | 1.14358972 |
| 67 | NTRK1 | 1.12755466 |
| 68 | CAMK1G | 1.12039037 |
| 69 | STK24 | 1.09681937 |
| 70 | IRAK1 | 1.09381136 |
| 71 | MAPK7 | 1.09021339 |
| 72 | TAOK2 | 1.05807728 |
| 73 | KIT | 1.05789301 |
| 74 | CAMK1 | 1.03171846 |
| 75 | TAOK3 | 1.02092620 |
| 76 | MAP3K13 | 1.01913706 |
| 77 | SGK3 | 1.01610309 |
| 78 | MAP4K1 | 1.00889195 |
| 79 | MAP3K11 | 0.98316875 |
| 80 | IKBKB | 0.95987300 |
| 81 | RIPK4 | 0.95270166 |
| 82 | CAMK2D | 0.94746740 |
| 83 | PRKCG | 0.92824941 |
| 84 | CAMK1D | 0.91278324 |
| 85 | PDPK1 | 0.89152659 |
| 86 | MAP2K6 | 0.89066594 |
| 87 | PRKCH | 0.88545939 |
| 88 | PRPF4B | 0.86542049 |
| 89 | MATK | 0.86175531 |
| 90 | FES | 0.85362044 |
| 91 | PIK3CG | 0.85269461 |
| 92 | LIMK1 | 0.84948395 |
| 93 | TNIK | 0.83996877 |
| 94 | SGK2 | 0.83605153 |
| 95 | MYLK | 0.81041078 |
| 96 | STK38L | 0.80834989 |
| 97 | MAP3K1 | 0.80696534 |
| 98 | SIK2 | 0.80578771 |
| 99 | ABL2 | 0.78569962 |
| 100 | PRKAA2 | 0.77933214 |
| 101 | PAK2 | 0.77664328 |
| 102 | IRAK2 | 0.77433223 |
| 103 | MAP3K7 | 0.75971528 |
| 104 | SYK | 0.75563741 |
| 105 | FGR | 0.75113767 |
| 106 | CDC42BPA | 0.74353593 |
| 107 | SIK3 | 0.73918848 |
| 108 | PRKG2 | 0.73520288 |
| 109 | NEK9 | 0.72734020 |
| 110 | HCK | 0.72103033 |
| 111 | STK10 | 0.71891853 |
| 112 | SCYL2 | 0.71555869 |
| 113 | LATS2 | 0.69997415 |
| 114 | TYRO3 | 0.68695224 |
| 115 | JAK2 | 0.66542742 |
| 116 | STK11 | 0.65193920 |
| 117 | BRD4 | 0.64136499 |
| 118 | CSF1R | 0.63096913 |
| 119 | GRK5 | 0.62835227 |
| 120 | CDK19 | 0.61895007 |
| 121 | MAPKAPK3 | 0.61458030 |
| 122 | MARK2 | 0.61410338 |
| 123 | ROCK1 | 0.60303154 |
| 124 | PRKD1 | 0.60155008 |
| 125 | MST4 | 0.59518129 |
| 126 | ITK | 0.59408780 |
| 127 | ALK | 0.59297560 |
| 128 | ICK | 0.59149140 |
| 129 | SGK223 | 0.58236048 |
| 130 | SGK494 | 0.58236048 |
| 131 | DDR2 | 0.57077909 |
| 132 | TIE1 | 0.57073486 |
| 133 | PRKCZ | 0.56585438 |
| 134 | DAPK3 | 0.54371132 |
| 135 | LCK | 0.53777195 |
| 136 | SGK1 | 0.52901197 |
| 137 | CAMK2A | 0.52716312 |
| 138 | PIM2 | 0.52666134 |
| 139 | ROCK2 | 0.51458469 |
| 140 | PDGFRB | 0.50937202 |
| 141 | INSRR | 0.50675381 |
| 142 | RPS6KA2 | 0.50196180 |
| 143 | FER | 0.49513471 |
| 144 | EPHA3 | 0.48991124 |
| 145 | UHMK1 | 0.48767191 |
| 146 | CAMK4 | 0.48631871 |
| 147 | ADRBK2 | 0.48165781 |
| 148 | PRKCE | 0.47844849 |
| 149 | MAPK4 | 0.44454779 |
| 150 | FLT3 | 0.44098697 |
| 151 | MAP3K6 | 0.42729068 |
| 152 | RPS6KA3 | 0.42079881 |
| 153 | PRKACG | 0.41665002 |
| 154 | PDGFRA | 0.40573304 |
| 155 | PAK3 | 0.39222665 |
| 156 | WNK4 | 0.38455104 |
| 157 | MAPK12 | 0.37333482 |
| 158 | MAP2K1 | 0.37167885 |
| 159 | SIK1 | 0.36862671 |
| 160 | FGFR4 | 0.36657310 |
| 161 | PRKAA1 | 0.35790195 |
| 162 | FGFR3 | 0.35280813 |
| 163 | RAF1 | 0.35042749 |
| 164 | FYN | 0.34533144 |
| 165 | ERN1 | 0.33833837 |
| 166 | RPS6KB1 | 0.33660689 |
| 167 | MUSK | 0.31394655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.46470568 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.41184299 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.24970433 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.19178935 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.15179458 |
| 6 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09379566 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.08352723 |
| 8 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.08098176 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.01247544 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.00167724 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.97574892 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.92086264 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.89618382 |
| 14 | Other glycan degradation_Homo sapiens_hsa00511 | 1.86699131 |
| 15 | Lysosome_Homo sapiens_hsa04142 | 1.84635307 |
| 16 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.79819456 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76847253 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.76646866 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.74748610 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.73552197 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.71228480 |
| 22 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.69957849 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.69257054 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68658756 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63938719 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.63618500 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61590099 |
| 28 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.61153756 |
| 29 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59309973 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.55486724 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.54061466 |
| 32 | * Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.52405802 |
| 33 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.51738624 |
| 34 | GABAergic synapse_Homo sapiens_hsa04727 | 1.51295127 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.50681736 |
| 36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.49873566 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.48483881 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45990299 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.45962248 |
| 40 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.45914255 |
| 41 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.45261744 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.44746507 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.43922507 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.43830948 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.43389471 |
| 46 | Allograft rejection_Homo sapiens_hsa05330 | 1.42698156 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 1.41971968 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.40655137 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.39425073 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.37587025 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.37039873 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35273603 |
| 53 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34359235 |
| 54 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32813302 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.32517319 |
| 56 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30962475 |
| 57 | Amoebiasis_Homo sapiens_hsa05146 | 1.27817237 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.27653614 |
| 59 | Renin secretion_Homo sapiens_hsa04924 | 1.27545006 |
| 60 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.27251880 |
| 61 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.25402075 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 1.23215808 |
| 63 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22367214 |
| 64 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.22332012 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22189606 |
| 66 | Viral myocarditis_Homo sapiens_hsa05416 | 1.18013353 |
| 67 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.16576741 |
| 68 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.15294644 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14050437 |
| 70 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12989367 |
| 71 | Taste transduction_Homo sapiens_hsa04742 | 1.09980368 |
| 72 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.09966159 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.09937794 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.06514259 |
| 75 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.06210212 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 1.01271684 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.99017079 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.97628874 |
| 79 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.97407508 |
| 80 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.96893794 |
| 81 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96124271 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95929841 |
| 83 | Carbon metabolism_Homo sapiens_hsa01200 | 0.95913046 |
| 84 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95023247 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.94962837 |
| 86 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94870532 |
| 87 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94540715 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94300151 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93173391 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91906924 |
| 91 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.91850709 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.91691053 |
| 93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.91190808 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89764387 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89578642 |
| 96 | Cocaine addiction_Homo sapiens_hsa05030 | 0.89169579 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.88704288 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.86701916 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.86058652 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.84341445 |
| 101 | Measles_Homo sapiens_hsa05162 | 0.84185335 |
| 102 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83800330 |
| 103 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83655995 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.83617762 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.83317930 |
| 106 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82972026 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.82470079 |
| 108 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.82422516 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81717733 |
| 110 | Long-term depression_Homo sapiens_hsa04730 | 0.80336755 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.79591234 |
| 112 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.79339589 |
| 113 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76997011 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76882059 |
| 115 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76818361 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.74370274 |
| 117 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.72591852 |
| 118 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.71862259 |
| 119 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.71079476 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70190177 |
| 121 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69181995 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67089086 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66557750 |
| 124 | Gap junction_Homo sapiens_hsa04540 | 0.66480445 |
| 125 | Shigellosis_Homo sapiens_hsa05131 | 0.65409387 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.63480441 |
| 127 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63274796 |
| 128 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62716370 |
| 129 | * Insulin resistance_Homo sapiens_hsa04931 | 0.61663382 |
| 130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60901026 |
| 131 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60024756 |
| 132 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59862529 |
| 133 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59615041 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58770240 |
| 135 | ABC transporters_Homo sapiens_hsa02010 | 0.58763116 |
| 136 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58228573 |
| 137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.57869815 |
| 138 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57814270 |
| 139 | * Circadian rhythm_Homo sapiens_hsa04710 | 0.57717694 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.56319615 |
| 141 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.55847922 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.53734985 |
| 143 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53658538 |
| 144 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53123733 |
| 145 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.53036076 |
| 146 | Melanogenesis_Homo sapiens_hsa04916 | 0.52757882 |
| 147 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.52476887 |
| 148 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51856915 |
| 149 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51666757 |
| 150 | Focal adhesion_Homo sapiens_hsa04510 | 0.51359636 |
| 151 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.51274259 |
| 152 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51266140 |
| 153 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51125786 |
| 154 | Endocytosis_Homo sapiens_hsa04144 | 0.50997288 |
| 155 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50383154 |
| 156 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49708633 |
| 157 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49669129 |
| 158 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49340797 |
| 159 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48084272 |
| 160 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48006046 |
| 161 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44506133 |
| 162 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44120822 |
| 163 | Lysine degradation_Homo sapiens_hsa00310 | 0.43799538 |
| 164 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43130890 |
| 165 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40167099 |
| 166 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39732371 |
| 167 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.38894514 |
| 168 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37479791 |
| 169 | Peroxisome_Homo sapiens_hsa04146 | 0.37420546 |
| 170 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.37289304 |
| 171 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.36396309 |

